BIOCRYST PHARMACEUTICA
7.7950
08-November-24 15:41:03
15 minutes delayed
Stocks
+0.1250
+1.63%
Today's range
7.5200 - 7.8400
ISIN
N/A
Source
NASDAQ
-
29 Nov 2023 07:00:00 By Nasdaq GlobeNewswire
-
BioCryst to Present at Upcoming Investor Conferences
21 Nov 2023 16:01:44 By Nasdaq GlobeNewswire
-
BioCryst Launches ORLADEYO® (berotralstat) in Spain
21 Nov 2023 07:00:13 By Nasdaq GlobeNewswire
-
10 Nov 2023 07:00:00 By Nasdaq GlobeNewswire
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06 Nov 2023 16:01:28 By Nasdaq GlobeNewswire
-
03 Nov 2023 12:03:00 By Nasdaq GlobeNewswire
-
03 Nov 2023 12:00:00 By Nasdaq GlobeNewswire
-
BioCryst Reports Third Quarter 2023 Financial Results and Provides Business Update
02 Nov 2023 07:00:55 By Nasdaq GlobeNewswire
-
27 Oct 2023 07:00:00 By Nasdaq GlobeNewswire
-
26 Oct 2023 07:00:00 By Nasdaq GlobeNewswire
-
BioCryst to Host R&D Day on November 3
20 Oct 2023 07:00:08 By Nasdaq GlobeNewswire
-
BioCryst to Report Third Quarter 2023 Financial Results on November 2
19 Oct 2023 07:00:16 By Nasdaq GlobeNewswire
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 Oct 2023 07:00:41 By Nasdaq GlobeNewswire
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 Sep 2023 07:00:46 By Nasdaq GlobeNewswire
-
BioCryst to Present at Upcoming Investor Conferences
23 Aug 2023 16:01:54 By Nasdaq GlobeNewswire
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 Aug 2023 16:01:28 By Nasdaq GlobeNewswire
-
BioCryst Reports Second Quarter 2023 Financial Results and Provides Business Update
03 Aug 2023 07:00:58 By Nasdaq GlobeNewswire
-
BioCryst to Report Second Quarter 2023 Financial Results on August 3
20 Jul 2023 07:00:37 By Nasdaq GlobeNewswire
-
BioCryst Selects Er-Kim Pharmaceuticals as Commercial Partner for ORLADEYO® (berotralstat) in Turkey
19 Jul 2023 07:00:00 By Nasdaq GlobeNewswire
-
BioCryst to Participate in the 2023 US HAEA National Summit
17 Jul 2023 07:00:00 By Nasdaq GlobeNewswire